Maia Biotechnology Inc (MAIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,601 | 7,151 | 10,951 | 10,574 | N/A |
| Receivables | 77 | 145 | 303 | 44 | N/A |
| TOTAL | $10,153 | $7,564 | $11,808 | $10,673 | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 3 | 3 | 214 | 655 | 0 |
| TOTAL | $3 | $3 | $214 | $655 | $N/A |
| Total Assets | $10,155 | $7,567 | $12,022 | $11,327 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,512 | 1,639 | 1,166 | 960 | 0 |
| Accrued Expenses | 2,318 | 3,299 | 2,103 | 1,186 | N/A |
| TOTAL | $3,830 | $4,937 | $3,269 | $2,146 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,691 | 2,152 | 245 | 74 | 0 |
| TOTAL | $2,691 | $2,152 | $245 | $N/A | $N/A |
| Total Liabilities | $6,521 | $7,089 | $3,514 | $2,146 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,587 | 20,003 | 10,996 | N/A | N/A |
| Common Shares | 3 | 2 | 1 | 1 | N/A |
| Retained earnings | -87,235 | -63,980 | -44,207 | -28,438 | N/A |
| Other shareholders' equity | -31 | -16 | -16 | 0 | 0 |
| TOTAL | $3,635 | $478 | $8,508 | $9,181 | $N/A |
| Total Liabilities And Equity | $10,155 | $7,567 | $12,022 | $11,327 | $0 |